Microbix Biosystems Inc. (MBXBF)
OTCMKTS · Delayed Price · Currency is USD
0.1580
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Microbix Biosystems Market Cap
Microbix Biosystems has a market cap or net worth of $23.45 million as of February 12, 2026. Its market cap has decreased by -48.42% in one year.
Market Cap
23.45M
Enterprise Value
21.81M
Revenue
12.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.16
Market Cap Chart
Since October 1, 1992, Microbix Biosystems's market cap has increased from 10.76M to 23.45M, an increase of 117.92%. That is a compound annual growth rate of 2.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 23.45M | 0.58% |
| Dec 31, 2025 | 23.31M | -39.12% |
| Dec 31, 2024 | 38.30M | -5.03% |
| Dec 29, 2023 | 40.33M | -4.23% |
| Dec 30, 2022 | 42.11M | -51.03% |
| Dec 31, 2021 | 85.98M | 136.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arch Biopartners | 43.72M |
| ZIVO Bioscience | 40.17M |
| Cell Source | 38.23M |
| Harvard Apparatus Regenerative Technology | 31.12M |
| Oncotelic Therapeutics | 27.82M |
| EOM Pharmaceuticals Holdings | 22.63M |
| Finch Therapeutics Group | 22.08M |
| Zenith Capital | 20.77M |